Loading chat...

MD SB875

Bill

Status

Introduced

2/3/2025

Primary Sponsor

William Folden

Click for details

Origin

Senate

2025 Regular Session

AI Summary

  • Retailers may only sell medetomidine or xylazine products to purchasers who provide proof of institutional, veterinary, or scientific purpose, and all buyers must be at least 21 years old

  • Retailers must maintain records of all sales, including copies of age verification identification and documentation of the purchaser's intended use

  • Civil penalties for violations are $3,000 for a first offense and $6,500 for each subsequent violation

  • All collected civil penalties must be deposited into the Maryland Substance Abuse Fund

  • Effective date: October 1, 2025

Legislative Description

Public Health – Medetomidine and Xylazine Consumer Protection Act

Records

Last Action

Hearing 3/11 at 1:00 p.m.

3/4/2025

Committee Referrals

Finance2/3/2025

Full Bill Text

No bill text available